Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more
Market Cap & Net Worth: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (SHE:301126) has a market capitalization of $332.58 Million (CN¥2.44 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #15737 globally and #4195 in its home market, demonstrating a -2.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's stock price CN¥11.88 by its total outstanding shares 205403200 (205.40 Million).
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Market Cap History: 2021 to 2026
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market capitalization history from 2021 to 2026. Data shows change from $629.97 Million to $332.58 Million (-14.75% CAGR).
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market cap is 0.06 times its annual revenue
7.95x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
11.00x
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market cap is 11.00 times its annual earnings
1.77x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $629.97 Million | $2.59 Billion | $68.26 Million | 0.24x | 9.23x |
| 2022 | $414.24 Million | $3.29 Billion | $51.08 Million | 0.13x | 8.11x |
| 2023 | $363.27 Million | $3.90 Billion | $34.30 Million | 0.09x | 10.59x |
| 2024 | $292.26 Million | $5.23 Billion | $26.57 Million | 0.06x | 11.00x |
Competitor Companies of 301126 by Market Capitalization
Companies near Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market cap moved from $629.97 Million to $ 332.58 Million, with a yearly change of -14.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥332.58 Million | -3.34% |
| 2025 | CN¥344.05 Million | +17.72% |
| 2024 | CN¥292.26 Million | -19.55% |
| 2023 | CN¥363.27 Million | -12.30% |
| 2022 | CN¥414.24 Million | -34.24% |
| 2021 | CN¥629.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $332.58 Million USD |
| MoneyControl | $332.58 Million USD |
| MarketWatch | $332.58 Million USD |
| marketcap.company | $332.58 Million USD |
| Reuters | $332.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.